▲ Peaking
Health
An Alzheimer’s Drug Cut Expected Cognitive Decline Roughly in Half. It Didn’t Target Amyloid
A new Alzheimer's drug called diranersen has demonstrated the ability to cut expected cognitive decline roughly in half by targeting tau rather than amyloid.